A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

ONC001 is a first-in-class antibody-drug conjugate (ADC) designed to uniquely target CD64, a myeloid-restricted receptor pervasively expressed in CMML and M4/M5 acute myeloid leukemia, including ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. The updated ...

CLN-049, a novel FLT3/CD3 bispecific T-cell engager, has received fast track designation from the FDA for the treatment of ...

Czech National Bank Governor Aleš Michl says the country’s Bitcoin (CRYPTO: BTC) $1 million purchase is meant to "touch reality" as he warns the ...

Cullinan Therapeutics (NASDAQ:CGEM) saw its stock rise 2.9% in Monday’s premarket session after announcing that the U.S. Food and Drug Administration has awarded Fast Track designation to CLN-049, its ...

Final 5-year data from the phase 2 2102-HEM-101 trial (NCT02719574) show that olutasidenib (Rezlidhia; Rigel Pharmaceuticals, ...

November 2025 saw pivotal FDA approvals, including durvalumab for gastric cancers and pembrolizumab/enfortumab vedotin for ...

In this article, the BitHide team breaks down how business operations are “read” on the blockchain, why traditional privacy schemes (mixers, privacy coins) no ...

Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 to address a broad ...

WhiteBIT, the largest European cryptocurrency exchange by traffic, today announced its official launch in the United States, ...

Biggest stock gainers. Synopsys +8% - Shares climbed after Nvidia invested $2B in Synopsys at $414.79 per share and announced a bro ...